Similarly, CD161+γδT cells were enriched in the liver of NAFLD patients, suggesting that γδT cells produced by IL-17A are important regulatory factors for the progression of NAFLD [156]. The gene discussed is KLRB1; the disease is metabolic dysfunction-associated steatotic liver disease.